InvesT1D: Promoting Adolescent Investment in Diabetes Care

This study, called InvesT1D, is looking at whether giving financial incentives (money) can help teenagers with type 1 diabetes better manage their condition. Participants will be between 12 and 18 years old and have had type 1 diabetes for at least a year. They also need to use a continuous glucose monitor (CGM) and either use it less than 70% of the time or give themselves insulin shots (boluses) less than 3 times a day on average. Some teens will receive financial rewards for reaching diabetes goals, while others will continue their usual care. The main goal is to see if these incentives improve their "Time In Range" (how long their blood sugar stays in a healthy range) over 12 to 18 months. Researchers will also look at how teens and their caregivers feel about their diabetes management.

Study design
This is an interventional study with 96 participants. Participants will be assigned to one of six groups, some receiving financial incentives and others continuing usual care.
What's involved
Participants will choose diabetes self-management goals, such as increasing daily insulin shots or CGM wear time. Researchers will collect data from participants and their caregivers.
Compensation
Participants in some groups will receive financial incentives (money) when they meet their selected goals.
Follow-up
Changes in glucose levels will be measured over 12 to 18 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06384911

InvesT1D: Promoting Adolescent Investment in Diabetes Care

Recruiting
NAAges 12+InterventionalTreatment
Harvard Pilgrim Health Care
~96 participants
Updated 2025-12-16 on ClinicalTrials.gov
What's tested:Financial Incentives Program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time In Range
Measured over Change over 12-18 months
Type 1 Diabetes
1 sites across 1 states
Washington1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosed with type 1 diabetes ≥12 months
Utilize a continuous glucose monitor (CGM) to support diabetes management
Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day
Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
Cognitively able to participate in incentive program and complete surveys
Have access to a mobile phone to receive information about goal attainment and incentive updates
Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team
Caregivers are willing to participate in study and complete surveys

Exclusion

At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day
Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
Cognitively or physically unable to participate
Adolescent is a ward of the state
Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
Caregivers are not willing to participate in study and complete surveys
  • Time In RangeChange over 12-18 months

    Continuous glucose monitor sensor glucose measurements collected during the intervention that are in range (70-180 mg/dL)